Pergolide-Associated Valvular Heart Disease
Comprehensive Therapy2006Vol. 32(2), pp. 94–101
Citations Over TimeTop 20% of 2006 papers
Related Papers
- → Dopamine agonists and cardiac valvulopathy in Parkinson disease(2006)111 cited
- → Echocardiography for the Detection of Valvulopathy Associated with the Use of Ergot-Derived Dopamine Agonists in Patients with Parkinson's Disease(2011)22 cited
- → The Impact in Japan of Regulatory Action on Prescribing of Dopamine Receptor Agonists(2011)18 cited
- → Pleural Effusion Associated With Pergolide Treatment(2009)1 cited
- → High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease(2008)13 cited